Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
Open accessAbstract
OBJECTIVE—Activation of the receptor for advanced glycation end products (RAGE) in diabetic vasculature is considered to be a key mediator of atherogenesis. This study examines the effects of deletion of RAGE on the development of atherosclerosis in the diabetic apoE−/− model of accelerated atherosclerosis. RESEARCH DESIGN AND METHODS—ApoE−/− and RAGE−/−/apoE−/− double knockout mice were rendered diabetic with streptozotocin and followed for 20 weeks, at which time plaque accumulation was assessed by en face analysis. RESULTS—Although diabetic apoE−/− mice showed increased plaque accumulation (14.9 ± 1.7%), diabetic RAGE−/−/apoE−/− mice had significantly reduced atherosclerotic plaque area (4.9 ± 0.4%) to levels not significantly different from control apoE−/− mice (4.3 ± 0.4%). These beneficial effects on the vasculature were associated with attenuation of leukocyte recruitment; decreased expression of proinflammatory mediators, including the nuclear factor-κB subunit p65, VCAM-1, and MCP-1; and reduced oxidative stress, as reflected by staining for nitrotyrosine and reduced expression of various NADPH oxidase subunits, gp91phox, p47phox, and rac-1. Both RAGE and RAGE ligands, including S100A8/A9, high mobility group box 1 (HMGB1), and the advanced glycation end product (AGE) carboxymethyllysine were increased in plaques from diabetic apoE−/− mice. Furthermore, the accumulation of AGEs and other ligands to RAGE was reduced in diabetic RAGE−/−/apoE−/− mice. CONCLUSIONS—This study provides evidence for RAGE playing a central role in the development of accelerated atherosclerosis associated with diabetes. These findings emphasize the potential utility of strategies targeting RAGE activation in the prevention and treatment of diabetic macrovascular complications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
RAGE has been implicated in both diabetes- and obesity-related atherosclerosis in ApoE-deficient mice.
“RAGe has been implicated in both diabetes- and obesity-related atherosclerosis using apolipoprotein e (APOe)-deficient mice, which are susceptible to developing atherosclerosis99,100.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735 · see citing works
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · see citing works
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · see citing works
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 826 · see citing works
Self-citationYONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716 · see citing works
Wendt, T., Tanji, N., Guo, J., Kislinger, T., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L., Moser, B., Markowitz, G. S., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 599 · see citing works
Self-citationRAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 562 · see citing works
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525 · see citing works
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M. E., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 525 · see citing works
Self-citationDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475 · see citing works
Liliensiek, B., Weigand, M. A., Bierhaus, A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418704 · Cited by 468 · see citing works
Self-citationFu, M.-X., Wells‐Knecht, K. J., Blackledge, J. A., Lyons, T. J., Thorpe, S. R., & Baynes, J. (1994) · Diabetes · doi:10.2337/diab.43.5.676 · Cited by 464 · see citing works
Wautier, J., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 434 · see citing works
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L., Sousa, M. M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 370 · see citing works
Self-citationVascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K. M., Kalea, A. Z., Lu, Y., Rosario, R., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 365 · see citing works
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A. M., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314 · see citing works
Self-citationCentral role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317115 · Cited by 313 · see citing works
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily
Bierhaus, A., Haslbeck, K.-M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A. R., Andrassy, M., Schiekofer, S., Schneider, J. G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18058 · Cited by 300 · see citing works
Self-citationCandido, R., Jandeleit-Dahm, K. A. M., Cao, Z., Nesteroff, S. P., Burns, W. C., Twigg, S. M., Dilley, R. J., Cooper, M. E., & Allen, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000021122.63813.32 · Cited by 261 · see citing works
Self-citationCD36: Implications in cardiovascular disease
Febbraio, M., & Silverstein, R. L. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.012 · Cited by 248 · see citing works
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 248 · see citing works
Lewis, P., Stefanovic, N., Pete, J., Calkin, A. C., Giunti, S., Thallas‐Bonke, V., Jandeleit-Dahm, K. A. M., Allen, T. J., Kola, I., Cooper, M. E., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.664250 · Cited by 246 · see citing works
Self-citationIrbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
Candido, R., Allen, T. J., Lassila, M., Cao, Z., Thallas, V., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2004) · Circulation · doi:10.1161/01.cir.0000124061.78478.94 · Cited by 194 · see citing works
Self-citationFebbraio, M., Guy, E. C., & Silverstein, R. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148007.06370.68 · Cited by 176 · see citing works
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 135 · see citing works
Self-citationMast cells: multipotent local effector cells in atherothrombosis
Kovanen, P. T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00515.x · Cited by 131 · see citing works
Calkin, A. C., Forbes, J. M., Smith, C. M., Lassila, M., Cooper, M. E., Jandeleit-Dahm, K. A. M., & Allen, T. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000177813.99577.6b · Cited by 128 · see citing works
Self-citationReceptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
Shoji, T., Koyama, H., Morioka, T., Tanaka, S., Kizu, A., Motoyama, K., Mori, K., Fukumoto, S., Shioi, A., Shimogaito, N., et al. (2006) · Diabetes · doi:10.2337/db05-1375 · Cited by 124 · see citing works
Fu, M.-X., Wells-Knecht, K. J., Blackledge, J. A., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.5.676 · Cited by 122 · see citing works
Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation
Andrassy, M., Igwe, J. C., Autschbach, F., Volz, C., Remppis, A. B., Neurath, M. F., Schleicher, E. D., Humpert, P. M., Wendt, T., Liliensiek, B., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050713 · Cited by 94 · see citing works
Self-citationCefalu, W. T., Wang, Z. Q., Bell-Farrow, A., Kiger, F. D., & Izlar, C. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.7.1317 · Cited by 92 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461 · see citing works
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works
Self-citationWang, S., Song, R., Wang, Z., Jing, Z., Wang, S., & Ma, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01298 · Cited by 1,450 · see citing works
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956 · see citing works
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751 · see citing works
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660 · see citing works
Self-citationThe RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381 · see citing works
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330 · see citing works
Gray, S. P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A. C., Biessen, E. A. L., Touyz, R. M., Cooper, M. E., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307012 · Cited by 189 · see citing works
Self-citationHofmann Bowman, M. A., Gawdzik, J., Bukhari, U., Husain, A. N., Toth, P. T., Kim, G., Earley, J., & McNally, E. M. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.217745 · Cited by 111 · see citing works
Prantner, D., Nallar, S., & Vogel, S. N. (2020) · The FASEB Journal · doi:10.1096/fj.202002136r · Cited by 92 · see citing works
Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes?
Hanssen, N. M. J., Kraakman, M. J., Flynn, M. C., Nagareddy, P. R., Schalkwijk, C. G., & Murphy, A. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.570553 · Cited by 90 · see citing works
Li, F., Cai, Z., Chen, F., Shi, X., Zhang, Q., Chen, S., Shi, J., Wang, D. W., & Dong, N. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0306-0 · Cited by 67 · see citing works
Ueno, H., Koyama, H., Shoji, T., Monden, M., Fukumoto, S., Tanaka, S., Otsuka, Y., Mima, Y., Morioka, T., Mori, K., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.006 · Cited by 65 · see citing works
Di Marco, E., Gray, S. P., Chew, P., Kennedy, K., Cooper, M. E., Schmidt, H. H. H. W., & Jandeleit-Dahm, K. A. M. (2016) · Clinical Science · doi:10.1042/cs20160249 · Cited by 37 · see citing works
Self-citationSaito, R., Araki, S., Yamamoto, Y., & Kusuhara, K. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0262 · Cited by 8 · see citing works
Schleicher, E. D. (2010) · Kidney International · doi:10.1038/ki.2010.146 · Cited by 3 · see citing works
- Authors
- Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., Thomas, M., Forbes, J. M., Nawroth, P. P., Bierhaus, A., Cooper, M. E., & Jandeleit-Dahm, K. A.
- Affiliations
- Albert Einstein Juvenile Diabetes Research Foundation Centre for Diabetes Complications, Diabetes Metabolism Division, Baker Heart Research Institute, Melbourne, Australia
- Baker Heart and Diabetes Institute (AU)
- Heidelberg University (DE)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-09-01
- Volume
- 57
- Issue
- 9
- Pages
- 2461-2469
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2518498
- OpenAlex
- W2129902595
- Cited by
- 407
- References
- 32
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 11 · 2023: 13 · 2022: 24 · 2021: 20 · 2020: 21 · 2019: 16 · 2018: 25 · 2017: 18 · 2016: 37 · 2015: 24 · 2014: 25 · 2013: 31 · 2012: 29
- FWCI
- 20.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Diabetes Australia
- Kidney Health Australia
- Orionin Tutkimussäätiö
- National Institutes of Health
- National Health and Medical Research Council
- National Heart, Lung, and Blood Institute (5R0-HL-083452-02, R01HL083452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- receptor for advanced glycation end products, atherosclerosis, diabetic atherosclerosis, atherosclerotic plaque, ApoE-deficient mice, streptozotocin-induced diabetes, leukocyte recruitment, pro-inflammatory mediators, NF-κB p65, VCAM-1, MCP-1, oxidative stress, NADPH oxidase, S100A8/A9, HMGB1, advanced glycation end products, carboxymethyllysine, diabetic macrovascular complications
- MeSH terms
- Animals, Apolipoproteins E, Collagen, Diabetic Angiopathies, Energy Metabolism, Macrophages, T-Lymphocytes, Vasculitis, Biomarkers, Gene Expression, Glycation End Products, Advanced, Mice, Knockout, Oxidative Stress, NADPH Oxidases, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Myocytes, Smooth Muscle, Receptor, Angiotensin, Type 1, Atherosclerosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
